Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

AR positive + ER positive

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

ER mutation (18)

ESR1 mutation (9)

AR mutation (9)

ER positive + ESR1 mutation (6)

AR splice variant 7 (5)

ER negative + PIK3CA H1047R (2)

PIK3CA mutation + ESR1 mutation (2)

AR wild-type (2)

ER D538G + ER F404L (1)

ER E380Q + ER F404L (1)

ER rs2234693 (1)

ESR1 rs1801132 (1)

ESR1 rs2228480 (1)

ESR1 rs2234693T>C (1)

ESR1 rs9322354 (1)

HR positive + PIK3CA H1047R (1)

HR positive + PIK3CA H1047R + ER D538G (1)

HR positive + PIK3CA H1047R + PIK3CA D350G + ER D538G (1)

PIK3CA H1047R + PIK3CA D959N + ER E380Q (1)

PIK3CA mutation + ER mutation (1)

AKT1 mutation + AR mutation (1)

AR F877L + AR T878A (1)

AR T878A + AR H875Y (1)

AR T878S + AR H875Y (1)

AR splice variant 7 negative (1)

AR splice variant 9 (1)

HER-2 negative + HR positive + ESR1 mutation + PIK3CA mutation (0)

ER mutation (18)

ESR1 mutation (9)

AR mutation (9)

ER positive + ESR1 mutation (6)

AR splice variant 7 (5)

ER negative + PIK3CA H1047R (2)

PIK3CA mutation + ESR1 mutation (2)

AR wild-type (2)

ER D538G + ER F404L (1)

ER E380Q + ER F404L (1)

ER rs2234693 (1)

ESR1 rs1801132 (1)

ESR1 rs2228480 (1)

ESR1 rs2234693T>C (1)

ESR1 rs9322354 (1)

HR positive + PIK3CA H1047R (1)

HR positive + PIK3CA H1047R + ER D538G (1)

HR positive + PIK3CA H1047R + PIK3CA D350G + ER D538G (1)

PIK3CA H1047R + PIK3CA D959N + ER E380Q (1)

PIK3CA mutation + ER mutation (1)

AKT1 mutation + AR mutation (1)

AR F877L + AR T878A (1)

AR T878A + AR H875Y (1)

AR T878S + AR H875Y (1)

AR splice variant 7 negative (1)

AR splice variant 9 (1)

HER-2 negative + HR positive + ESR1 mutation + PIK3CA mutation (0)

›

AR positive + ER positive

HER2 Negative Breast Cancer

Sensitive: B - Late Trials

Sensitive: B - Late Trials